MGTXMeiraGTx Holdings plc
$12.01
$0.15
(1.23%)
Pre-Market
EarningsAug 13
Mkt Cap$1.13B
Vol9.00
Wall Street Analysts See a 128.14% Upside in MeiraGTx (MGTX): Can the Stock Really Move This High?
The mean of analysts' price targets for MeiraGTx (MGTX) points to a 128.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks
MeiraGTx (MGTX) Moves 5.5% Higher: Will This Strength Last?
MeiraGTx (MGTX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks
MeiraGTx Enters $400 Mln Investment Deal With Oberland Capital
(RTTNews) - MeiraGTx Holdings plc (MGTX), a clinical-stage genetic medicine company, on Tuesday entered into an agreement with Oberland Capital Management for an investment of up to $400 million...
Nasdaq News: Markets
Can MeiraGTx Holdings PLC (MGTX) Stock Double? Cash Runway Offers a Hint
Can MeiraGTx Holdings PLC (MGTX) Stock Double? Cash Runway Offers a Hint...
Yahoo! Finance: News
MeiraGTx Holdings PLC (MGTX) Reports Q1 Loss, Lags Revenue Estimates
MeiraGTx (MGTX) delivered earnings and revenue surprises of -32.56% and -81.10%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Will Alector (ALEC) Report Negative Q1 Earnings? What You Should Know
Alector (ALEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
Enanta Pharmaceuticals (ENTA) Moves 5.3% Higher: Will This Strength Last?
Enanta Pharmaceuticals (ENTA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks
Foghorn Therapeutics Inc. (FHTX) Reports Q1 Loss, Lags Revenue Estimates
Foghorn Therapeutics (FHTX) delivered earnings and revenue surprises of -3.57% and -64.62%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
MeiraGTx (MGTX) Projected to Post Quarterly Earnings on Tuesday
MeiraGTx (NASDAQ:MGTX) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-12-meiragtx-holdings-plc-stock...
MarketBeat
Will MeiraGTx Holdings PLC (MGTX) Report Negative Q1 Earnings? What You Should Know
MeiraGTx (MGTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
<
1
2
...
>
Advertisement|Remove ads.
GOOGL15
24
SMCI19
30
RKLB8
14Advertisement|Remove ads.